255 related articles for article (PubMed ID: 16151345)
21. Biofilm prevention on cochlear implants.
Goldfinger Y; Natan M; Sukenik CN; Banin E; Kronenberg J
Cochlear Implants Int; 2014 May; 15(3):173-8. PubMed ID: 24679102
[TBL] [Abstract][Full Text] [Related]
22. Role of biofilm in Staphylococcus aureus and Staphylococcus epidermidis ventricular assist device driveline infections.
Toba FA; Akashi H; Arrecubieta C; Lowy FD
J Thorac Cardiovasc Surg; 2011 May; 141(5):1259-64. PubMed ID: 20709333
[TBL] [Abstract][Full Text] [Related]
23. Detection of bacteria in healthy middle ears during cochlear implantation.
Tonnaer EL; Mylanus EA; Mulder JJ; Curfs JH
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):232-7. PubMed ID: 19289699
[TBL] [Abstract][Full Text] [Related]
24. Microflora of Retained Intracochlear Electrodes from Infected Cochlear Implants.
Varadarajan VV; Dirain CO; Antonelli PJ
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):85-91. PubMed ID: 28195822
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients.
Barbieri R; Pesce M; Franchelli S; Baldelli I; De Maria A; Marchese A
BMC Microbiol; 2015 Feb; 15(1):26. PubMed ID: 25888077
[TBL] [Abstract][Full Text] [Related]
26. Imaging studies of bacterial biofilms on cochlear implants-Bioactive glass (BAG) inhibits mature biofilm.
Kirchhoff L; Arweiler-Harbeck D; Arnolds J; Hussain T; Hansen S; Bertram R; Buer J; Lang S; Steinmann J; Höing B
PLoS One; 2020; 15(2):e0229198. PubMed ID: 32084198
[TBL] [Abstract][Full Text] [Related]
27. Postoperative infections following cochlear implant surgery.
Olsen LB; Larsen S; Wanscher JH; Faber CE; Jeppesen J
Acta Otolaryngol; 2018 Oct; 138(10):956-960. PubMed ID: 30015553
[TBL] [Abstract][Full Text] [Related]
28. Conservative management of infections in cochlear implant recipients.
Yu KC; Hegarty JL; Gantz BJ; Lalwani AK
Otolaryngol Head Neck Surg; 2001 Jul; 125(1):66-70. PubMed ID: 11458217
[TBL] [Abstract][Full Text] [Related]
29. A modified chronic infection model for testing treatment of Staphylococcus aureus biofilms on implants.
Jørgensen NP; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
PLoS One; 2014; 9(10):e103688. PubMed ID: 25279456
[TBL] [Abstract][Full Text] [Related]
30. Infectious complications in pediatric cochlear implants.
Hopfenspirger MT; Levine SC; Rimell FL
Laryngoscope; 2007 Oct; 117(10):1825-9. PubMed ID: 17690611
[TBL] [Abstract][Full Text] [Related]
31. Adherence and biofilm formation of Staphylococcus epidermidis and Mycobacterium tuberculosis on various spinal implants.
Ha KY; Chung YG; Ryoo SJ
Spine (Phila Pa 1976); 2005 Jan; 30(1):38-43. PubMed ID: 15626979
[TBL] [Abstract][Full Text] [Related]
32. Possible role of biofilm in fulminant meningitis related to cochlear implantation of dysplastic inner ear.
Makarem AO; Schaudinn C; Webster P; Linthicum FH
Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):245-8. PubMed ID: 19408503
[TBL] [Abstract][Full Text] [Related]
33. Diabetic mouse model of orthopaedic implant-related Staphylococcus aureus infection.
Lovati AB; Drago L; Monti L; De Vecchi E; Previdi S; Banfi G; Romanò CL
PLoS One; 2013; 8(6):e67628. PubMed ID: 23818985
[TBL] [Abstract][Full Text] [Related]
34. The genetics of staphylococcal biofilm formation--will a greater understanding of pathogenesis lead to better management of device-related infection?
Fitzpatrick F; Humphreys H; O'Gara JP
Clin Microbiol Infect; 2005 Dec; 11(12):967-73. PubMed ID: 16307550
[TBL] [Abstract][Full Text] [Related]
35. Biofilm formation in an in vitro model of cochlear implants with removable magnets.
Loeffler KA; Johnson TA; Burne RA; Antonelli PJ
Otolaryngol Head Neck Surg; 2007 Apr; 136(4):583-8. PubMed ID: 17418256
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of antibiotic treatment of implant-associated
Greimel F; Scheuerer C; Gessner A; Simon M; Kalteis T; Grifka J; Benditz A; Springorum HR; Schaumburger J
Drug Des Devel Ther; 2017; 11():1729-1736. PubMed ID: 28652709
[TBL] [Abstract][Full Text] [Related]
37. Biofilm formation in cochlear implants with cochlear drug delivery channels in an in vitro model.
Johnson TA; Loeffler KA; Burne RA; Jolly CN; Antonelli PJ
Otolaryngol Head Neck Surg; 2007 Apr; 136(4):577-82. PubMed ID: 17418255
[TBL] [Abstract][Full Text] [Related]
38. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
39. Surface charge modification decreases Pseudomonas aeruginosa adherence in vitro and bacterial persistence in an in vivo implant model.
Kao WK; Gagnon PM; Vogel JP; Chole RA
Laryngoscope; 2017 Jul; 127(7):1655-1661. PubMed ID: 28295372
[TBL] [Abstract][Full Text] [Related]
40. Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors.
Nishitani K; Sutipornpalangkul W; de Mesy Bentley KL; Varrone JJ; Bello-Irizarry SN; Ito H; Matsuda S; Kates SL; Daiss JL; Schwarz EM
J Orthop Res; 2015 Sep; 33(9):1311-9. PubMed ID: 25820925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
